部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,468 | 100.0% | 1,925 | 100.0% | 1,543 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 269 | 7.8% | 184 | 9.6% | 85 | 5.5% |
食道 | C15 | 266 | 7.7% | 223 | 11.6% | 43 | 2.8% |
胃 | C16 | 266 | 7.7% | 194 | 10.1% | 72 | 4.7% |
大腸 | C18-C20 | 209 | 6.0% | 133 | 6.9% | 76 | 4.9% |
( 結腸 ) | C18 | 137 | 4.0% | 81 | 4.2% | 56 | 3.6% |
( 直腸S状結腸移行部、直腸) | C19-C20 | 72 | 2.1% | 52 | 2.7% | 20 | 1.3% |
膵 | C25 | 174 | 5.0% | 100 | 5.2% | 74 | 4.8% |
気管、気管支及び肺 | C33-C34 | 245 | 7.1% | 165 | 8.6% | 80 | 5.2% |
血液、骨髄 | C420 C421 | 110 | 3.2% | 66 | 3.4% | 44 | 2.9% |
皮膚(黒色腫以外) | C44 | 105 | 3.0% | 53 | 2.8% | 52 | 3.4% |
乳房 | C50 | 310 | 8.9% | 2 | 0.1% | 308 | 20.0% |
子宮 | C53-C55 | 227 | 6.5% | - | - | 227 | 14.7% |
( 子宮頚 ) | C53 | 114 | 3.3% | - | - | 114 | 7.4% |
( 子宮体部 ) | C54 | 113 | 3.3% | - | - | 113 | 7.3% |
( 子宮NOS ) | C55 | 0 | 0.0% | - | - | 0 | 0.0% |
前立腺 | C61 | 252 | 7.3% | 252 | 13.1% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 155 | 4.5% | 83 | 4.3% | 72 | 4.7% |
悪性リンパ腫 | M959-M972 | 142 | 4.1% | 80 | 4.2% | 62 | 4.0% |
その他(100件未満) | 738 | 21.3% | 390 | 20.3% | 348 | 22.6% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 93.1% | 92.9% | 66.7% | 0.0% | 100.0% | 0.0% | 83.0% |
手術 | 33.1% | 92.9% | 66.7% | 0.0% | 6.7% | 0.0% | 32.6% |
(うち、体腔鏡的治療) | 28.1% | 42.9% | 16.7% | 0.0% | 6.7% | 0.0% | 24.3% |
内視鏡的治療 | 62.5% | 0.0% | 0.0% | 0.0% | 93.3% | 0.0% | 52.3% |
放射線療法 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
化学療法 | 4.4% | 50.0% | 100.0% | 78.3% | 0.0% | 0.0% | 17.4% |
その他 | 0.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 95.2% | 92.9% | 92.3% | 65.0% | 100.0% | 0.0% | 91.6% |
手術 | 12.5% | 85.7% | 92.9% | 92.3% | 65.0% | 20.6% | 0.0% | 62.6% |
(うち、体腔鏡的治療) | 12.5% | 76.2% | 64.3% | 46.2% | 35.0% | 8.8% | 0.0% | 44.3% |
内視鏡的治療 | 100.0% | 14.3% | 0.0% | 0.0% | 0.0% | 82.4% | 0.0% | 32.1% |
放射線療法 | 0.0% | 0.0% | 7.1% | 7.7% | 0.0% | 0.0% | 0.0% | 1.5% |
化学療法 | 0.0% | 9.5% | 35.7% | 30.8% | 75.0% | 5.9% | 0.0% | 22.9% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 63.6% | 38.5% | 44.4% | 45.5% | 100.0% | 100.0% | 53.4% |
手術 | 63.6% | 38.5% | 22.2% | 27.3% | 100.0% | 100.0% | 46.5% |
(うち、体腔鏡的治療) | 18.2% | 7.7% | 11.1% | 0.0% | 0.0% | 0.0% | 10.3% |
内視鏡的治療 | 0.0% | 0.0% | 22.2% | 18.2% | 0.0% | 0.0% | 6.9% |
放射線療法 | 0.0% | 0.0% | 0.0% | 9.1% | 0.0% | 0.0% | 1.7% |
化学療法 | 27.3% | 61.5% | 44.4% | 54.5% | 0.0% | 100.0% | 43.1% |
TAE | 27.3% | 53.8% | 44.4% | 9.1% | 0.0% | 100.0% | 32.8% |
レーザー等治療 | 13.6% | 7.7% | 0.0% | 0.0% | 0.0% | 0.0% | 6.9% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 74.1% | 64.7% | 24.2% | 0.0% | 100.0% | 0.0% | 48.7% |
手術 | 100.0% | 74.1% | 64.7% | 24.2% | 0.0% | 100.0% | 0.0% | 48.6% |
(うち、体腔鏡的治療) | 100.0% | 71.8% | 58.8% | 9.1% | 0.0% | 100.0% | 0.0% | 44.3% |
内視鏡的治療 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
放射線療法 | 0.0% | 21.2% | 11.8% | 51.5% | 12.2% | 0.0% | 0.0% | 23.0% |
化学療法 | 0.0% | 5.9% | 41.2% | 54.5% | 73.2% | 0.0% | 0.0% | 32.8% |
レーザー等治療 | 0.0% | 2.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% |
その他 | 0.0% | 0.0% | 0.0% | 0.0% | 2.4% | 0.0% | 0.0% | 0.5% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 93.1% | 97.6% | 86.5% | 59.3% | 0.0% | 100.0% | 0.0% | 78.8% |
放射線療法 | 31.0% | 40.5% | 29.7% | 7.4% | 8.7% | 33.3% | 0.0% | 29.1% |
化学療法 | 6.9% | 23.8% | 51.4% | 85.2% | 56.5% | 33.3% | 0.0% | 38.4% |
内分泌療法 | 55.2% | 65.5% | 45.9% | 25.9% | 47.8% | 66.7% | 0.0% | 53.2% |
(重複あり)